Skip to main content
. 2022 Jul 18;12:12266. doi: 10.1038/s41598-022-16403-z

Table 3.

Multivariable analysis of patient’s medical and health risk factors associated with the severity level of fall.

Risk category Risk condition SAC 3 n (%) (n = 3545) SAC 2 n (%) (n = 142) SAC 1 n (%) (n = 18) Estimate (SD) p-value Adj. odds [95% confidence interval]
History of fall No falls history 1,414 (37.0) 52 (36.6) 10 (55.6) − 0.010 (0.262) 0.969 0.990 [0.593, 1.653]
> 1 fall in previous 6 months 1,472 (38.5) 47 (33.1) 5 (27.8) 0.192 (0.222) 0.387 1.212 [0.784, 1.873]
Admitted because of a fall 638 (16.7) 27 (19.0) 4 (22.2) − 0.122 (0.238) 0.608 0.885 [0.555, 1.411]
Had fall/s or near miss/es during current admission 775 (20.3) 34 (23.9) 3 (16.7) − 0.399 (0.237) 0.092 0.671 [0.422, 1.067]
Behavioural No behaviour/mental state/cognition issues 1,049 (27.4) 40 (28.2) 6 (33.3) − 0.113 (0.250) 0.652 0.893 [0.547, 1.459]
Dehydration 226 (5.9) 6 (4.2) 1 (5.6) 0.352 (0.424) 0.406 1.422 [0.620, 3.260]
Delirium, anxiety, agitation issues 1,072 (28.0) 35 (24.6) 6 (33.3) 0.001 (0.217) 0.996 1.001 [0.654, 1.531]
Dementia/cognitive impairment issues 1,014 (26.5) 36 (25.4) 3 (16.7) 0.033 (0.222) 0.883 1.033 [0.669, 1.597]
Difficulty communicating or following instructions 1,045 (27.3) 35 (24.6) 4 (22.2) 0.021 (0.217) 0.922 1.022 [0.667, 1.563]
Impaired consciousness 192 (5.0) 10 (7.0) 1 (5.6) − 0.531 (0.344) 0.123 0.588 [0.300, 1.154]
Intellectual disability affecting judgement of physical ability 157 (4.1) 2 (1.4) 1 (5.6) 0.500 (0.602) 0.406 1.649 [0.507, 5.363]
Marked depression 131 (3.4) 9 (6.3) 2 (11.1) − 0.983 (0.362) 0.007* 0.374 [0.184, 0.760]
Neurological condition 750 (19.6) 27 (19.0) 2 (11.1) − 0.195 (0.270) 0.470 0.823 [0.484, 1.398]
Under the influence of alcohol or illicit drugs 105 (2.7) 13 (9.2) 0 (0.0) − 1.452 (0.357) < 0.001* 0.234 [0.116, 0.472]
Mobility No mobility transfer issues 217 (5.7) 13 (9.2) 0 (0.0) 0.183 (0.344) 0.594 1.201 [0.612, 2.355]
Dizziness, light-headedness, faintness, dehydration 541 (14.2) 21 (14.8) 0 (0.0) 0.117 (0.256) 0.647 1.124 [0.681, 1.855]
Impaired lower limb peripheral sensation 486 (12.7) 12 (8.5) 3 (16.7) 0.249 (0.303) 0.411 1.283 [0.708, 2.325]
Lower limb amputee 76 (2.0) 1 (0.7) 0 (0.0) 1.149 (1.022) 0.261 3.155 [0.425, 23.392]
Non or partial weight-bearing 274 (7.2) 6 (4.2) 1 (5.6) 0.587 (0.418) 0.160 1.798 [0.793, 4.077]
Poor balance, unsteady 2,333 (61.0) 70 (49.3) 12 (66.7) 0.483 (0.192) 0.012* 1.622 [1.114, 2.361]
Poor vision, such that it affects mobility 283 (7.4) 11 (7.7) 1 (5.6) 0.031 (0.318) 0.922 1.032 [0.553, 1.925]
Requires assistance to mobilise 1,727 (45.2) 56 (39.4) 9 (50.0) 0.051 (0.197) 0.796 1.052 [0.715, 1.549]
Requires standby assistance 1,500 (39.2) 39 (27.5) 11 (61.1) 0.387 (0.190) 0.042* 1.473 [1.014, 2.138]
Requires walking aid or similar e.g., crutches, walking frame 1,462 (38.2) 49 (34.5) 10 (55.6) − 0.073 (0.197) 0.711 0.930 [0.632, 1.368]
Severe foot problems—pain, deformity, or marked swelling 249 (6.5) 12 (8.5) 1 (5.6) − 0.482 (0.334) 0.149 0.618 [0.321, 1.188]
Significant pain when walking, transferring 253 (6.6) 13 (9.2) 1 (5.6) − 0.445 (0.312) 0.154 0.641 [0.348, 1.182]
Urge incontinence, occasional incontinence 590 (15.4) 22 (15.5) 4 (22.2) − 0.204 (0.235) 0.384 0.815 [0.515, 1.291]
Weakness, generalised muscular weakness 1,142 (29.9) 31 (21.8) 7 (38.9) 0.266 (0.205) 0.195 1.305 [0.873, 1.951]
Medication Medication issues 1,061 (27.8) 55 (38.7) 5 (27.8) − 0.623 (0.260) 0.017* 0.537 [0.322, 0.893]
Diuretics 490 (12.8) 17 (12.0) 2 (11.1) − 0.071 (0.275) 0.797 0.932 [0.543, 1.598]
General Anaesthetic (within 24/24) 69 (1.8) 5 (3.5) 0 (0.0) − 0.754 (0.502) 0.133 0.470 [0.176, 1.257]
Polypharmacy—more than 5 prescribed medications 1,877 (49.1) 59 (41.5) 12 (66.7) − 0.297 (0.243) 0.221 0.743 [0.462, 1.196]
Psychoactive medications—antidepressants or benzodiazepines 654 (17.1) 21 (14.8) 2 (11.1) 0.180 (0.268) 0.501 1.197 [0.708, 2.023]
Sedation within 12/24 of assessment 304 (8.0) 8 (5.6) 0 (0.0) 0.423 (0.389) 0.277 1.527 [0.712, 3.274]
Substantial change to medication regime 118 (3.1) 1 (0.7) 1 (5.6) 0.682 (0.727) 0.348 1.978 [0.476, 8.222]
Physiological Anticoagulant therapy/bleeding disorder 1650 () 49 () 12 (66.7) 0.124 (0.205) 0.545 1.133 [0.757, 1.694]
Diagnosis of osteoporosis 118 3.1) 5 (3.5) 0 (0.0) − 0.124 (0.447) 0.782 0.884 [0.368, 2.121]
Fragile skin 1318 (37.2) 61 (43.0) 10 (55.6) − 0.559 (0.214) 0.001* 0.572 [0.376, 0.869]

NB: Patients with risk condition present were set as reference group in the model. *Denotes significant association at 5% level of significance. The reported adjusted odds estimates are also age-gender adjusted.